Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.778 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.660 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.623 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.609 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.588 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.587 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.583 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.583 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.582 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.579 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.562 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.537 | |
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.533 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.530 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.527 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.522 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.518 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.516 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.509 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.508 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.503 | |
| 2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.502 | |
| 3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.502 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.499 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.499 | |
| 3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.498 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.495 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.493 | |
| 3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.485 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.484 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.479 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.479 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.477 | |
| 3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.474 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.473 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.471 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.466 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.466 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.465 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.461 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.461 | |
| 2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.460 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.457 | |
| 4kio | G5K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.457 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.453 | |
| 3ol5 | SAW | Camphor 5-monooxygenase | 1.14.15.1 | 0.452 | |
| 1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.450 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.449 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.449 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.448 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.448 | |
| 2f4b | EHA | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.447 | |
| 3ag9 | A02 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.447 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.447 | |
| 4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.446 | |
| 4g7g | VFV | Lanosterol 14-alpha-demethylase | / | 0.446 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.446 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
| 3nbw | TR4 | Ketohexokinase | / | 0.444 | |
| 4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.444 | |
| 4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
| 4g3j | VNT | Lanosterol 14-alpha-demethylase | / | 0.443 | |
| 3qai | XNN | Ketohexokinase | / | 0.442 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.441 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.441 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.440 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 |